AOP Orphan announces positive CHMP opinion fo...

Wien (pts012/17.12.2018/11:35) – * AOP Orphan’s EMA marketing authorization application...

AOP Orphan announces two-year results on Ropeginterferon alfa-2bin PV

AOP Orphan announces two-year results on Rope...

Wien/Atklanta (pts021/11.12.2017/13:30) – * High rates and durable Clinical and...

AOP Orphan and PharmaEssentia announce pivotal phase III results for ropeginterferon alfa-2b in PV

AOP Orphan and PharmaEssentia announce pivota...

Wien (pts017/05.12.2016/11:20) – AOP Orphan and PharmaEssentia announce pivotal phase...